Business

Announcement on Presentation of Preclinical Study Data of Innovative Drugs KC1086 and KC1101 at the AACR Annual Meeting 2026

Announcement on Presentation of Preclinical Study Data of Innovative Drugs KC1086 and KC1101 at the AACR Annual Meeting 2026

articleBeijing Konruns Pharmaceutical Co., Ltd. Class AApril 23, 20264/news/announcement-on-presentation-of-preclinical-study-data-of-innovative-drugs-kc1086-and-kc1101-at-the-aacr-annual-meeting-2026
Announcement on Presentation of Preclinical Study Data of Innovative Drugs KC1086 and KC1101 at the AACR Annual Meeting 2026

About this update from Beijing Konruns Pharmaceutical Co., Ltd. Class A

Announcement on Presentation of Preclinical Study Data of Innovative Drugs KC1086 and KC1101 at the AACR Annual Meeting 2026 The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Beijing Konruns Pharmaceutical Co., Ltd. Class A